Gastric cancer (GC) is one of the most common cancers in the world and the leading cause of cancer-related death in China. At present, the intervention measures for GC are limited. Therefore, it is particularly important to find biological markers and targeted therapy for the occurrence and development of GC. Galectin-1 (Gal-1) is a member of the human lectin family and has attracted attention for its association with human tumor invasion behavior. Recent studies have found that the expression of Gal-1 in tumor cells is closely related to the migration, invasion and tumor-induced angiogenesis of tumor cells. This article reviews the research progress of Gal-1 in GC, which is helpful to discover the therapeutic effect of Gal-1 in GC diseases.
References
[1]
Li, Z., Liu, K., Zhang, W., et al. (2024) Epidemiological Characteristics and Trends of Gastric Cancer in the World and China: Interpretation of ‘Global Cancer Statistics Report’ 2018-2022. ChineseJournalofBasicandClinicalGeneralSurgery, 31, 1236-1245.
[2]
Wong, M.C.S., Huang, J., Chan, P.S.F., Choi, P., Lao, X.Q., Chan, S.M., etal. (2021) Global Incidence and Mortality of Gastric Cancer, 1980-2018. JAMANetworkOpen, 4, e2118457. https://doi.org/10.1001/jamanetworkopen.2021.18457
[3]
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., et al. (2021) Signaling Pathways in Cancer-Associated Fibroblasts and Targeted Therapy for Cancer. SignalTransductionandTargetedTherapy, 6, Article No. 218. https://doi.org/10.1038/s41392-021-00641-0
[4]
Girotti, M.R., Salatino, M., Dalotto-Moreno, T. and Rabinovich, G.A. (2019) Sweetening the Hallmarks of Cancer: Galectins as Multifunctional Mediators of Tumor Progression. JournalofExperimentalMedicine, 217, e20182041. https://doi.org/10.1084/jem.20182041
[5]
Navarro, P., Martínez-Bosch, N., Blidner, A.G. and Rabinovich, G.A. (2020) Impact of Galectins in Resistance to Anticancer Therapies. ClinicalCancerResearch, 26, 6086-6101. https://doi.org/10.1158/1078-0432.ccr-18-3870
[6]
Zhang, Q., Ali, M., Wang, Y., Sun, Q., Zhu, X., Tang, D., etal. (2022) Galectin-1 Binds GRP78 to Promote the Proliferation and Metastasis of Gastric Cancer. InternationalJournalofOncology, 61, Article No. 141. https://doi.org/10.3892/ijo.2022.5431
[7]
Zhi, M., Zhou, F.X., Guan, X., Zhong, J.W. and Luo, X.Q., etal. (2020) Study on the Inhibition of Th2-Type Inflammatory Response in Allergic Asthma Mice by Galectin-1. ChineseJournalofParasitologyandParasiticDiseases, 38, 213-218.
[8]
You, X., Wu, J., Zhao, X., Jiang, X., Tao, W., Chen, Z., etal. (2021) Fibroblastic Galectin-1-Fostered Invasion and Metastasis Are Mediated by TGF-β1-Induced Epithelial-Mesenchymal Transition in Gastric Cancer. Aging, 13, 18464-18481. https://doi.org/10.18632/aging.203295
[9]
Ma, Z., Chen, M., Yang, X., Xu, B., Song, Z., Zhou, B., et al. (2018) The Role of Cancer-Associated Fibroblasts in Tumorigenesis of Gastric Cancer. CurrentPharmaceuticalDesign, 24, 3297-3302. https://doi.org/10.2174/1381612824666180601094056
[10]
Yan, Y., Wang, L.-F. and Wang, R.-F. (2015) Role of Cancer-Associated Fibroblasts in Invasion and Metastasis of Gastric Cancer. WorldJournalofGastroenterology, 21, Article 9717. https://doi.org/10.3748/wjg.v21.i33.9717
[11]
Wei, J., Li, D.K., Hu, X., Cheng, C. and Zhang, Y. (2021) Galectin‐1-RNA Interaction Map Reveals Potential Regulatory Roles in Angiogenesis. FEBSLetters, 595, 623-636. https://doi.org/10.1002/1873-3468.14047
[12]
Tsai, Y., Li, C., Huang, Y., Chang, T., Lin, C., Chuang, C., et al. (2022) Galectin-1 Orchestrates an Inflammatory Tumor-Stroma Crosstalk in Hepatoma by Enhancing TNFR1 Protein Stability and Signaling in Carcinoma-Associated Fibroblasts. Oncogene, 41, 3011-3023. https://doi.org/10.1038/s41388-022-02309-7
[13]
Ma, S., Kong, S., Gu, X., Xu, Y., Tao, M., Shen, L., etal. (2021) As a Biomarker for Gastric Cancer, CircPTPN22 Regulates the Progression of Gastric Cancer through the EMT Pathway. CancerCellInternational, 21, Article No. 44. https://doi.org/10.1186/s12935-020-01701-1
[14]
Díaz del Arco, C., Estrada Muñoz, L., Cerón Nieto, M.Á., Molina Roldán, E., Fernández Aceñero, M.J. and García Gómez de las Heras, S. (2024) Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma. Biomedicines, 12, Article 1508. https://doi.org/10.3390/biomedicines12071508
[15]
Ma, S., Liu, D., Tan, W., Du, B., Liu, W., Li, W., et al. (2020) Interference with SMO Increases Chemotherapy Drug Sensitivity of A2780/DDP Cells by Inhibiting the Hh/Gli Signaling Pathway. JournalofCellularBiochemistry, 121, 3256-3265. https://doi.org/10.1002/jcb.29593
[16]
You, X., Wu, J., Wang, Y., Liu, Q., Cheng, Z., Zhao, X., et al. (2020) Galectin-1 Promotes Vasculogenic Mimicry in Gastric Adenocarcinoma via the Hedgehog/Gli Signaling Pathway. Aging, 12, 21837-21853. https://doi.org/10.18632/aging.104000
[17]
Wu, M., Ying, N., Hong, T., Chiang, W., Lin, Y. and Chen, Y. (2014) Galectin-1 Induces Vascular Permeability through the Neuropilin-1/Vascular Endothelial Growth Factor Receptor-1 Complex. Angiogenesis, 17, 839-849. https://doi.org/10.1007/s10456-014-9431-8
[18]
Papavassiliou, A.G. and Musti, A.M. (2020) The Multifaceted Output of C-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion. Cells, 9, Article 2470. https://doi.org/10.3390/cells9112470
[19]
Li, J., Pan, C., Boese, A.C., Kang, J., Umano, A.D., Magliocca, K.R., etal. (2020) DGKA Provides Platinum Resistance in Ovarian Cancer through Activation of C-JUN-WEE1 Signaling. ClinicalCancerResearch, 26, 3843-3855. https://doi.org/10.1158/1078-0432.ccr-19-3790
[20]
Pan, Z., Xu, G., Zhang, Y., Wu, M., Yu, J., He, X., etal. (2024) Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance through the NRP-1/c-JUN/Wee1 Pathway. JournalofGastricCancer, 24, 300-315. https://doi.org/10.5230/jgc.2024.24.e25
[21]
Goud, N.S. and Bhattacharya, A. (2021) Human Galectin-1 in Multiple Cancers: A Privileged Molecular Target in Oncology. Mini-ReviewsinMedicinalChemistry, 21, 2169-2186. https://doi.org/10.2174/1389557521666210217093815
[22]
Nambiar, D.K., Aguilera, T., Cao, H., Kwok, S., Kong, C., Bloomstein, J., etal. (2019) Galectin-1-Driven T Cell Exclusion in the Tumor Endothelium Promotes Immunotherapy Resistance. JournalofClinicalInvestigation, 129, 5553-5567. https://doi.org/10.1172/jci129025
[23]
Corral, J.M., del Puerto-Nevado, L., Cedeño, M., Río-Vilariño, A., Mahillo-Fernández, I., Galeano, C., etal. (2022) Galectin-1, a Novel Promising Target for Outcome Prediction and Treatment in SCLC. Biomedicine&Pharmacotherapy, 156, Article 113987. https://doi.org/10.1016/j.biopha.2022.113987
[24]
Astorgues-Xerri, L., Riveiro, M.E., Tijeras-Raballand, A., Serova, M., Neuzillet, C., Albert, S., et al. (2014) Unraveling Galectin-1 as a Novel Therapeutic Target for Cancer. CancerTreatmentReviews, 40, 307-319. https://doi.org/10.1016/j.ctrv.2013.07.007
